Edition:
United States

Acrux Ltd (ACR.AX)

ACR.AX on Australia Stock Exchange

0.25AUD
23 May 2017
Change (% chg)

$0.00 (+0.99%)
Prev Close
$0.25
Open
$0.26
Day's High
$0.26
Day's Low
$0.25
Volume
1,031,660
Avg. Vol
399,992
52-wk High
$0.83
52-wk Low
$0.25

ACR.AX

Chart for ACR.AX

About

Acrux Limited is a drug development company. The Company is engaged in developing and commercializing branded and generic transdermal and topical pharmaceuticals for global markets. The Company's transdermal or topical pharmaceutical product portfolio can be segregated into approximately two streams, such as generic pharmaceutic... (more)

Overall

Beta: 1.11
Market Cap(Mil.): $42.05
Shares Outstanding(Mil.): 166.52
Dividend: --
Yield (%): --

Financials

  ACR.AX Industry Sector
P/E (TTM): 4.28 14.32 17.37
EPS (TTM): 0.06 -- --
ROI: 19.45 -7.73 -5.89
ROE: 20.99 -7.36 -5.30

BRIEF-Acrux Ltd reports quarterly global Axiron sales of US$39.9 mln

* Global Axiron net sales of US$39.9 million in its financial results for quarter ending 31 Dec 2016, up from US$39.0 million for previous quarter Source text for Eikon: Further company coverage:

Jan 31 2017

More From Around the Web

Earnings vs. Estimates